DK1653963T3 - Nasal farmaceutisk sammensætning piribedil - Google Patents
Nasal farmaceutisk sammensætning piribedilInfo
- Publication number
- DK1653963T3 DK1653963T3 DK04767691T DK04767691T DK1653963T3 DK 1653963 T3 DK1653963 T3 DK 1653963T3 DK 04767691 T DK04767691 T DK 04767691T DK 04767691 T DK04767691 T DK 04767691T DK 1653963 T3 DK1653963 T3 DK 1653963T3
- Authority
- DK
- Denmark
- Prior art keywords
- piribedil
- pharmaceutical composition
- nasal pharmaceutical
- nasal
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0308712A FR2857594B1 (fr) | 2003-07-17 | 2003-07-17 | Composition pharmaceutique pour l'administration par voie nasale de piribedil |
| PCT/FR2004/001867 WO2005009442A1 (fr) | 2003-07-17 | 2004-07-16 | Composition pharmaceutique pour l’administration par voie nasale de piribedil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1653963T3 true DK1653963T3 (da) | 2007-04-10 |
Family
ID=33548200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04767691T DK1653963T3 (da) | 2003-07-17 | 2004-07-16 | Nasal farmaceutisk sammensætning piribedil |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US20060204449A1 (da) |
| EP (1) | EP1653963B1 (da) |
| JP (1) | JP2007516947A (da) |
| KR (1) | KR100807480B1 (da) |
| CN (1) | CN100540004C (da) |
| AR (1) | AR046808A1 (da) |
| AT (1) | ATE349213T1 (da) |
| AU (1) | AU2004258714A1 (da) |
| BR (1) | BRPI0412681A (da) |
| CA (1) | CA2532631C (da) |
| CY (1) | CY1106013T1 (da) |
| DE (1) | DE602004003955T2 (da) |
| DK (1) | DK1653963T3 (da) |
| EA (1) | EA011041B1 (da) |
| ES (1) | ES2279435T3 (da) |
| FR (1) | FR2857594B1 (da) |
| GE (1) | GEP20074259B (da) |
| HK (1) | HK1094153A1 (da) |
| HR (1) | HRP20070081T5 (da) |
| MA (1) | MA27864A1 (da) |
| MX (1) | MXPA06000641A (da) |
| MY (1) | MY137747A (da) |
| NO (1) | NO332776B1 (da) |
| NZ (1) | NZ544460A (da) |
| PL (1) | PL1653963T3 (da) |
| PT (1) | PT1653963E (da) |
| SI (1) | SI1653963T1 (da) |
| UA (1) | UA85193C2 (da) |
| WO (1) | WO2005009442A1 (da) |
| ZA (1) | ZA200600240B (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2726833C (en) * | 2008-06-06 | 2016-03-22 | Pharma Two B Ltd. | Pharmaceutical compositions for treatment of parkinson's disease |
| US20160022572A1 (en) * | 2013-03-13 | 2016-01-28 | N To B Ltd. | Methods, compositions and devices for treatment of motor and depression symptoms associated with parkinson's disease |
| IT201800005117A1 (it) | 2018-05-07 | 2019-11-07 | Acqua irradiata con energie elettromagnetiche per uso terapeutico |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE1007402A5 (nl) * | 1993-03-26 | 1995-06-06 | Adir | Nasale farmaceutische preparaten met progestagene stof. |
| PT689438E (pt) * | 1993-03-26 | 2003-10-31 | Franciscus Wilhelmus He Merkus | Composicoes farmaceuticas para administracao intranasal de apomorfina |
| FR2710268B1 (fr) * | 1993-09-22 | 1995-10-20 | Adir | Utilisation de beta-cyclodextrines partiellement méthylées comme promoteurs d'absorption dans la préparation de compositions pharmaceutiques pour l'administration transcutanée de principes actifs. |
| FR2710265B1 (fr) * | 1993-09-22 | 1995-10-20 | Adir | Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs. |
| FR2742989B1 (fr) * | 1995-12-29 | 1998-01-23 | Adir | Composition pharmaceutique bioadhesive pour la liberation controlee de principes actifs |
| JP2001518923A (ja) * | 1997-03-26 | 2001-10-16 | ダブリュ エイチ エム マーカス，フランシスカス | 鼻腔用メラトニン組成物 |
| EP0900567A3 (en) * | 1997-09-05 | 2001-05-02 | Pfizer Products Inc. | Quinazoline-4-one AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy |
| US20020002175A1 (en) * | 2000-09-19 | 2002-01-03 | Charanjit Behl | Nasal delivery of apomorphine in combination with glycol derivatives |
| US20040028613A1 (en) * | 2001-06-25 | 2004-02-12 | Nastech Pharmaceutical Company Inc | Dopamine agonist formulations for enhanced central nervous system delivery |
| FR2827516B1 (fr) * | 2001-07-19 | 2003-09-19 | Servier Lab | Composition pharmaceutique pour l'administration par voie nasale d'estradiol et de norethisterone |
-
2003
- 2003-07-17 FR FR0308712A patent/FR2857594B1/fr not_active Expired - Fee Related
-
2004
- 2004-07-15 MY MYPI20042838A patent/MY137747A/en unknown
- 2004-07-15 AR ARP040102489A patent/AR046808A1/es unknown
- 2004-07-16 PT PT04767691T patent/PT1653963E/pt unknown
- 2004-07-16 SI SI200430163T patent/SI1653963T1/sl unknown
- 2004-07-16 NZ NZ544460A patent/NZ544460A/en not_active IP Right Cessation
- 2004-07-16 GE GEAP20049239A patent/GEP20074259B/en unknown
- 2004-07-16 JP JP2006519966A patent/JP2007516947A/ja active Pending
- 2004-07-16 UA UAA200601630A patent/UA85193C2/ru unknown
- 2004-07-16 WO PCT/FR2004/001867 patent/WO2005009442A1/fr active IP Right Grant
- 2004-07-16 ZA ZA200600240A patent/ZA200600240B/en unknown
- 2004-07-16 CN CNB2004800197495A patent/CN100540004C/zh not_active Expired - Fee Related
- 2004-07-16 US US10/564,139 patent/US20060204449A1/en not_active Abandoned
- 2004-07-16 MX MXPA06000641A patent/MXPA06000641A/es active IP Right Grant
- 2004-07-16 BR BRPI0412681-5A patent/BRPI0412681A/pt not_active IP Right Cessation
- 2004-07-16 AT AT04767691T patent/ATE349213T1/de active
- 2004-07-16 CA CA2532631A patent/CA2532631C/fr not_active Expired - Fee Related
- 2004-07-16 EP EP04767691A patent/EP1653963B1/fr not_active Expired - Lifetime
- 2004-07-16 AU AU2004258714A patent/AU2004258714A1/en not_active Abandoned
- 2004-07-16 KR KR1020067001141A patent/KR100807480B1/ko not_active IP Right Cessation
- 2004-07-16 ES ES04767691T patent/ES2279435T3/es not_active Expired - Lifetime
- 2004-07-16 DK DK04767691T patent/DK1653963T3/da active
- 2004-07-16 PL PL04767691T patent/PL1653963T3/pl unknown
- 2004-07-16 DE DE602004003955T patent/DE602004003955T2/de not_active Expired - Lifetime
- 2004-07-16 EA EA200600172A patent/EA011041B1/ru not_active IP Right Cessation
-
2005
- 2005-12-27 MA MA28688A patent/MA27864A1/fr unknown
-
2006
- 2006-02-16 NO NO20060743A patent/NO332776B1/no not_active IP Right Cessation
-
2007
- 2007-01-24 HK HK07100838.9A patent/HK1094153A1/xx not_active IP Right Cessation
- 2007-02-13 CY CY20071100190T patent/CY1106013T1/el unknown
- 2007-02-28 HR HR20070081T patent/HRP20070081T5/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE380544T1 (de) | Umhüllte feste darreichungsform | |
| DK1545662T3 (da) | Lægemiddelindgivelsessystem | |
| CY2017048I1 (el) | Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης | |
| PT1501534E (pt) | Formulacoes farmaceuticas | |
| DE502004003234D1 (de) | Gegen missbrauch gesicherte darreichungsform | |
| DE502004004205D1 (de) | Gegen missbrauch gesicherte darreichungsform | |
| BRPI0511900A (pt) | composições farmacêuticas | |
| DE602004017700D1 (de) | Transmukosen verabreichung | |
| CY2018005I2 (el) | Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης | |
| IS8352A (is) | Ný rópínírólsamsetning | |
| PT1467724E (pt) | Composicao farmaceutica orodispersavel de agomelatina | |
| DK1587478T3 (da) | Farmaceutisk sammensætning | |
| DE60335075D1 (de) | Flüssigkeitszerstäuber | |
| MA28603B1 (fr) | Composition pharmaceutique antimycobacterienne | |
| DE602004022810D1 (de) | Mehrdosis-inhalator | |
| NO20043489L (no) | Sammensetning for inhalering | |
| HK1094153A1 (en) | Nasal pharmaceutical composition of piribedil | |
| ITMI20041447A1 (it) | Composizione farmaceutica comprendente gabapentina | |
| NO20034952D0 (no) | Farmasöytiske forbindelser | |
| ITMI20040943A1 (it) | Composizione farmaceutica cicatrizzante | |
| DK1675637T3 (da) | Inhalator | |
| NO20044164L (no) | Farmasoytiske sammensetninger | |
| PT1467737E (pt) | Composicao farmaceutica orodispersivel de piribedil | |
| DE112004001429D2 (de) | Pharmazeutischer Wirkstoff | |
| DE502004004196D1 (de) | Ultraschall-stehwellen-zerstäuberanordnung |